Cargando…
Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses
For a particular subgroup of individuals with severe paraphilic disorders and a high risk of sexual recidivism, the combination of sex drive–reducing medications and psychotherapy is a promising treatment approach. The present quasi-experimental study aims at comparing differences in clinical charac...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072038/ https://www.ncbi.nlm.nih.gov/pubmed/32167420 http://dx.doi.org/10.1177/1079063220910723 |
_version_ | 1783683837630349312 |
---|---|
author | Sauter, Julia Turner, Daniel Briken, Peer Rettenberger, Martin |
author_facet | Sauter, Julia Turner, Daniel Briken, Peer Rettenberger, Martin |
author_sort | Sauter, Julia |
collection | PubMed |
description | For a particular subgroup of individuals with severe paraphilic disorders and a high risk of sexual recidivism, the combination of sex drive–reducing medications and psychotherapy is a promising treatment approach. The present quasi-experimental study aims at comparing differences in clinical characteristics and dynamic risk factors between persons receiving (+TLM, n = 38) versus not receiving (−TLM, n = 22) testosterone-lowering medications (TLMs). Individuals receiving TLM were more frequently diagnosed with paraphilic disorders. Neither the criminal history nor average risk scores differed between the two groups. In the +TLM, Stable-2007 scores showed a stronger decrease after TLM treatment was started. This accounted especially for the general and sexual self-regulation subscales. Individual variations in risk, however, were not predicted by TLM but were significantly related to treatment duration and Psychopathy Checklist–Revised (PCL-R) Factor I. Paraphilic patients with problems in self-regulatory abilities seem to profit most from pharmacological sex drive–reducing treatment. Furthermore, therapists seem to underestimate deviant sexual fantasies in medicated patients. |
format | Online Article Text |
id | pubmed-8072038 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-80720382021-05-13 Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses Sauter, Julia Turner, Daniel Briken, Peer Rettenberger, Martin Sex Abuse Articles For a particular subgroup of individuals with severe paraphilic disorders and a high risk of sexual recidivism, the combination of sex drive–reducing medications and psychotherapy is a promising treatment approach. The present quasi-experimental study aims at comparing differences in clinical characteristics and dynamic risk factors between persons receiving (+TLM, n = 38) versus not receiving (−TLM, n = 22) testosterone-lowering medications (TLMs). Individuals receiving TLM were more frequently diagnosed with paraphilic disorders. Neither the criminal history nor average risk scores differed between the two groups. In the +TLM, Stable-2007 scores showed a stronger decrease after TLM treatment was started. This accounted especially for the general and sexual self-regulation subscales. Individual variations in risk, however, were not predicted by TLM but were significantly related to treatment duration and Psychopathy Checklist–Revised (PCL-R) Factor I. Paraphilic patients with problems in self-regulatory abilities seem to profit most from pharmacological sex drive–reducing treatment. Furthermore, therapists seem to underestimate deviant sexual fantasies in medicated patients. SAGE Publications 2020-03-13 2021-06 /pmc/articles/PMC8072038/ /pubmed/32167420 http://dx.doi.org/10.1177/1079063220910723 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Articles Sauter, Julia Turner, Daniel Briken, Peer Rettenberger, Martin Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses |
title | Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses |
title_full | Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses |
title_fullStr | Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses |
title_full_unstemmed | Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses |
title_short | Testosterone-Lowering Medication and Its Association With Recidivism Risk in Individuals Convicted of Sexual Offenses |
title_sort | testosterone-lowering medication and its association with recidivism risk in individuals convicted of sexual offenses |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072038/ https://www.ncbi.nlm.nih.gov/pubmed/32167420 http://dx.doi.org/10.1177/1079063220910723 |
work_keys_str_mv | AT sauterjulia testosteroneloweringmedicationanditsassociationwithrecidivismriskinindividualsconvictedofsexualoffenses AT turnerdaniel testosteroneloweringmedicationanditsassociationwithrecidivismriskinindividualsconvictedofsexualoffenses AT brikenpeer testosteroneloweringmedicationanditsassociationwithrecidivismriskinindividualsconvictedofsexualoffenses AT rettenbergermartin testosteroneloweringmedicationanditsassociationwithrecidivismriskinindividualsconvictedofsexualoffenses |